BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
FDA recommends further naproxcinod trials in complete response letter to NicOx
July 22, 2010
Global registrational trial announced for rFVIIIFc in hemophilia A
July 12, 2010
EMA commences review of rosiglitazone-containing medicines
July 12, 2010
E.C. approves Reyataz capsules for HIV-1 in pediatric patients
July 9, 2010
Chewable Lipitor obtains European approval for use in children
July 8, 2010
EC approves new indication for Orencia in rheumatoid arthritis
July 7, 2010
EMA completes validation of Dyax's MAA for ecallantide
July 7, 2010
Nycomed receives European marketing authorization for roflumilast in COPD
July 7, 2010
Circadin approved in the E.U. for 13-week treatment for primary insomnia
July 6, 2010
Rifapentine obtains orphan drug status in Europe for tuberculosis
July 2, 2010
Previous
1
2
…
142
143
144
145
146
147
148
149
150
…
159
160
Next
RSS